Moderna makes booster shot case to U.S. advisers, leaning on Israel data, company studies

Written by on October 14, 2021

A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar

Oct 14 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday were set to vote on whether a third dose of Moderna Inc's



Current track

Title

Artist